231 related articles for article (PubMed ID: 21686224)
1. Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).
Sedor JR; Madhavan SM; Kim JH; Konieczkowski M
Trans Am Clin Climatol Assoc; 2011; 122():184-97. PubMed ID: 21686224
[TBL] [Abstract][Full Text] [Related]
2. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus.
Srichai MB; Konieczkowski M; Padiyar A; Konieczkowski DJ; Mukherjee A; Hayden PS; Kamat S; El-Meanawy MA; Khan S; Mundel P; Lee SB; Bruggeman LA; Schelling JR; Sedor JR
J Biol Chem; 2004 Apr; 279(14):14398-408. PubMed ID: 14736876
[TBL] [Abstract][Full Text] [Related]
3. Essential role of Wtip in mouse development and maintenance of the glomerular filtration barrier.
Madhavan SM; Konieczkowski M; Bruggeman LA; DeWalt M; Nguyen JK; O'Toole JF; Sedor JR
Am J Physiol Renal Physiol; 2022 Sep; 323(3):F272-F287. PubMed ID: 35862649
[TBL] [Abstract][Full Text] [Related]
4. Podocyte injury induces nuclear translocation of WTIP via microtubule-dependent transport.
Kim JH; Konieczkowski M; Mukherjee A; Schechtman S; Khan S; Schelling JR; Ross MD; Bruggeman LA; Sedor JR
J Biol Chem; 2010 Mar; 285(13):9995-10004. PubMed ID: 20086015
[TBL] [Abstract][Full Text] [Related]
5. WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment.
Rico M; Mukherjee A; Konieczkowski M; Bruggeman LA; Miller RT; Khan S; Schelling JR; Sedor JR
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F431-41. PubMed ID: 15798086
[TBL] [Abstract][Full Text] [Related]
6. Wtip- and gadd45a-interacting protein dendrin is not crucial for the development or maintenance of the glomerular filtration barrier.
Xiao Z; Rodriguez PQ; He L; Betsholtz C; Tryggvason K; Patrakka J
PLoS One; 2013; 8(12):e83133. PubMed ID: 24376653
[TBL] [Abstract][Full Text] [Related]
7. WT1-interacting protein (Wtip) regulates podocyte phenotype by cell-cell and cell-matrix contact reorganization.
Kim JH; Mukherjee A; Madhavan SM; Konieczkowski M; Sedor JR
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F103-15. PubMed ID: 21900451
[TBL] [Abstract][Full Text] [Related]
8. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
9. Identification of a putative network of actin-associated cytoskeletal proteins in glomerular podocytes defined by co-purified mRNAs.
Nabet B; Tsai A; Tobias JW; Carstens RP
PLoS One; 2009 Aug; 4(8):e6491. PubMed ID: 19652713
[TBL] [Abstract][Full Text] [Related]
10. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
11. Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.
Babayeva S; Zilber Y; Torban E
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F549-60. PubMed ID: 20534871
[TBL] [Abstract][Full Text] [Related]
12. Signaling in regulation of podocyte phenotypes.
Chuang PY; He JC
Nephron Physiol; 2009; 111(2):p9-15. PubMed ID: 19142027
[TBL] [Abstract][Full Text] [Related]
13. Role of Asxl1 in kidney podocyte development via its interaction with Wtip.
Moon S; Um SJ; Kim EJ
Biochem Biophys Res Commun; 2015 Oct; 466(3):560-6. PubMed ID: 26385183
[TBL] [Abstract][Full Text] [Related]
14. Prohibitin Signaling at the Kidney Filtration Barrier.
Ising C; Brinkkoetter PT
Adv Exp Med Biol; 2017; 982():563-575. PubMed ID: 28551807
[TBL] [Abstract][Full Text] [Related]
15. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
17. A Review of Podocyte Biology.
Garg P
Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
[TBL] [Abstract][Full Text] [Related]
18. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
[TBL] [Abstract][Full Text] [Related]
19. The role of podocytes in glomerular pathobiology.
Asanuma K; Mundel P
Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
